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Decrease in hyperosmotic stress–induced corneal epithelial cell
apoptosis by L-carnitine
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Brien Holden Vision Institute, Sydney, Australia; 2School of Optometry and Vision Science, University of NSW, Sydney, Australia;
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Purpose: To characterize the osmoprotective properties of L-carnitine on human corneal epithelial cell volume and
apoptosis during hyperosmotic stress.
Methods: Human corneal limbal epithelial (HCLE) cells were exposed to culture medium at 300 mOsm (isotonic) or
500 mOsm (hyperosmotic) with or without L-carnitine (10 mM). Induction of apoptosis was detected by quantifying
the proteolytic activity of caspase-8, caspase-9, and caspase-3/7 using caspase activity assays, the expression of tumor
necrosis factor (TNF)-α with enzyme-linked immunosorbent assay, and annexin V/propidium iodide staining of HCLE
cells evaluated with confocal microscopy and flow cytometry. Cell volume changes in response to hyperosmotic stress
were analyzed using flow cytometry.
Results: After the HCLE cells were exposed to hyperosmotic medium (500 mOsm), the percentage of shrunken cells
and damaged/dead cells (stained positively for annexin V and/or propidium iodide) was six- and three-fold, respectively,
higher than that under isotonic conditions (300 mOsm). This was paralleled by an increase in TNF-α concentration in
media and caspase-8, -9, and -3/7 activities (six-, four-, ten-, and twelve-fold, respectively; all showing p<0.001). Addition of L-carnitine during hyperosmotic stress partly restored cell volume and significantly reduced the concentration
of TNF-α released (p=0.005) and caspase-9 activity (p=0.0125). Addition of L-carnitine reduced the percentage of
hyperosmolarity-induced damaged/dead cells to levels observed under isotonic conditions.
Conclusions: L-carnitine can regulate human corneal epithelial cell volume under hyperosmotic stress and ameliorate
hyperosmotic stress–induced apoptosis.

Hyperosmolarity is a feature common to many cases of
dry eye disease, although there is sometimes a lack of correlation in studies between other dry eye tests and osmolality
measurements of the tear film. Hyperosmolarity can result
from either a decrease in tear secretion or an increase in tear
evaporation—the two pathways that produce ocular dryness
[1,2]. Tear osmolarity measured from the lower meniscus
of tears of patients with dry eye can reach values of up to
360 mOsm [3,4] compared with 300–310 mOsm in normal
eyes [5-7]. However, the osmolarity measured from the lower
meniscus might not fully reflect osmolarity over the ocular
surface. Although measuring the osmolarity directly over the
ocular surface has remained technically challenging, it has
been proposed that the tear film osmolarity in these regions
can increase to 450 to 600 mOsm [8-10].
Tear hyperosmolarity is the central mechanism in the
pathogenesis of ocular surface damage and is associated with
inflammation in dry eye disease [2,11]. An increase in tear
osmolarity has also been found to correlate with the severity
of dry eye disease across normal, mild/moderate, and severe
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categories [12]. Hyperosmolarity-associated ocular surface
damage and inflammation have been widely demonstrated
in studies using animal dry eye models [13-16] as well as in in
vitro human corneal epithelial cell culture models [17,18]. Tear
hyperosmolarity can damage the surface epithelium, which
can trigger production of signaling molecules, including
various interleukins, tumor necrosis factor, and matrix metalloproteinases [13,14,17,19], as well as decrease the number of
conjunctival goblet cells, which results in a disturbance of
mucin expression leading to tear instability and subsequent
increases in the ocular surface osmolarity, thus perpetuating
the inflammatory cycle [20,21]. Although a direct relationship
between high tear osmolarity and ocular surface damage has
not been firmly established in human subjects, Reinoso et al.
demonstrated significantly increased apoptosis levels in the
conjunctival epithelium of patients with evaporative dry eye
disease compared with normal eyes [22].
Exposure of the ocular surface to a hyperosmotic
environment causes an imbalance between the extracellular and intracellular compartments resulting in net efflux
of water from the ocular surface epithelial cells leading
to cell shrinkage [17,18,23]. Excessive alterations in cell
volume impinge upon cell survival, interfering with the cell
membrane, cytoskeletal integrity, and cytosolic proteins
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[24]. To counteract these harmful effects, the cells respond
through an immediate intracellular influx and accumulation
of components including inorganic ions through activation
of ion transporters, exchangers, or channels, which helps to
equilibrate osmolality and thus regulate cell volume [24].
The survival of hypertonicity-stressed corneal epithelial
cells depends on Na+ K+ 2Cl- cotransporter (NKCC) activity,
which is controlled by p38 mitogen-activated protein kinase
(MAPK) activation [25-27]. However, the accumulation of
inorganic ions in cells can interfere with normal cellular
processes and cause precipitation of cell macromolecules,
denaturation and destabilization of internal proteins, alterations in membrane potentials, and changes in the rates of
enzymatic reactions, leading to premature cell death [24,2832]. Hyperosmolarity-induced apoptosis in cultured human
ocular surface epithelial cells has been reported [33-35].
Cells can adapt to the hyperosmotic environment by
taking up organic osmolytes (also known as osmoprotectants)
[36], which, unlike inorganic ions, do not interfere with cell
metabolism or destabilize proteins, thus protecting against
cellular damage and helping cells survive and function [37].
L-carnitine is a naturally occurring amino acid best known
for its role in the mitochondrial oxidation of long chain fatty
acids [38]. Carnitine also participates in cell volume and
fluid balancing in all tissues affected by the tonicity (iso-,
hyper-, hypotonicity) of the extracellular environment [39].
In the kidney, osmolytes including carnitine are crucial in
maintaining cell volume in an environment of drastically
fluctuating tonicity resulting from fluctuations in increased
production of urine and antidiruesis. The resulting increased
extracellular osmolarity of medullary cells can be more
than four-fold that of isotonicity [40-42]. In the brain, the
role of carnitine in isotonicity is crucial since alteration of
tonicity affects nerve excitability due to ion fluctuation,
and brain cells cannot swell due to skull rigidity [39]. In
the ocular system, Corrales and colleagues [17] reported
that under hyperosmolar conditions, L-carnitine protects
cultured human corneal epithelial cells through its inhibition
of hyperosmolarity-induced activation of mitogen-activated
protein (MAP) kinases although the nature of the potential
interaction of L-carnitine with signaling pathways for MAP
kinases has not been explored. L-carnitine also protects rabbit
corneal epithelial cells from hyperosmotic stress in dry eye
models [43]. L-carnitine can also limit progression and reduce
the severity of mouse dry eye with demonstrated reduction
in corneal staining and several apoptotic epithelial cells [44].
In mammals, carnitine, obtained by in situ biosynthesis and
from the diet [45], is maintained at a steady-state concentration in many tissues such as skeletal and heart muscles,
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principally by the organic cation transporter (OCT) system,
specifically by OCTN1 and OCTN2 [46-48].
Previous studies demonstrated the presence of OCTN1
and OCTN2 in human and rabbit corneal and conjunctival
epithelial cells [49]. These transporters are upregulated under
hyperosmotic stress [49]. The level of L-carnitine in tears
is depleted during dry eye [50], and there are reports that
administering L-carnitine to the ocular surface improves the
common signs and symptoms of dry eye and reduces dry
eye–associated conjunctival staining [51].
In this study, we used an in vitro human corneal-limbal
epithelial (HCLE) culture model to determine the osmoprotective properties of L-carnitine through its ability to regulate
hyperosmolarity-induced cell volume changes and apoptosis
characterized by the proteolytic activity of caspase-8,
caspase-9, and caspase-3/7 and the release of tumor necrosis
factor (TNF)-α. We provide evidence demonstrating that
L-carnitine can aid in maintaining cell volume under hyperosmotic stress and ameliorate certain aspects of hyperosmotic
stress-induced apoptosis.
METHODS
Cell culture: An immortalized HCLE cell line derived from
primary cultures of HCLE cells (a kind gift from Dr. Ilene
Gipson, Schepens Eye Research Institute, Boston, MA) was
used in the study. Cells were maintained at 2×104/cm 2 in a
keratinocyte serum-free medium (K-SFM; Invitrogen-Gibco,
Grand Island, NY), supplemented with 25 μg/ml bovine
pituitary extract, 0.2 ng/ml epidermal growth factor (EGF;
Invitrogen, Mount Waverley, Australia), and 0.4 mM CaCl2,
and grown at 37 °C in a 5% carbon dioxide atmosphere. To
enhance nutrient composition, the cultures were switched at
approximately 50% confluence to a 1:1 mixture of K-SFM and
low calcium Dulbecco’s Modified Eagle Medium (DMEM)/
F12 medium (Invitrogen) to achieve confluence. For the
influence of Ca2+ on the cellular response to hyperosmolar
stress and the effect of L-carnitine, cells were transferred to a
1:1 mixture of K-SFM and 1.0 mM Ca2+ DMEM/F12 medium
to achieve confluence.
Exposure of human corneal-limbal epithelial cells to hyperosmotic conditions in the presence of L-carnitine: A hyperosmolar medium of 500 mOsm was achieved with the addition
of NaCl. Osmolality was confirmed using a Vapro 5520 vapor
pressure osmometer (Wescor, Logan, UT). HCLE cells with
70%–80% confluence were exposed to isotonic (300 mOsm)
or hypertonic media (500 mOsm) in the presence or absence
of 10 mM L-carnitine [17] or 10 mM D-carnitine (as a
comparison), for 16 h at 37 °C. The osmolarity and exposure
time were established previously, based on our preliminary
1946
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evidence indicating that the osmolarity of 500 mOsm and an
exposure time of 16 h were optimal for studying measurable
cellular responses [52].
Caspase activity assay: Luminescent assay kits (Promega,
Madison, WI) were used to measure the proteolytic activity
of caspase-8, caspase-9, and caspase-3/7. The assays were
performed according to the manufacturer’s instructions.
Brief ly, 100 µl of caspase-8, caspase-9, or caspase-3/7
luminogenic substrate reagents were added individually to
HCLE cells after 16 h exposure to isotonic or hyperosmotic
medium in the presence or absence of 10 mM L-carnitine.
The reagents and cells were incubated at room temperature
for 1 h after which the luminescence was measured using
a Tecan SpectraFluor Plus 137 microplate reader (Tecan,
Männedorf, Switzerland).
Measurement of tumor necrosis factor-α production: Production of TNF-α by HCLE cells in the culture supernatants was
evaluated using enzyme-linked immunosorbent assay (R&D
Systems, Minneapolis, MN) according to the manufacturer’s
instructions. The culture supernatants were collected, centrifuged at 239 ×g for 5 min to remove the detached cells, and
stored at −80 °C until processed. Absorbance was measured
at 540 nm using a Multiskan spectrum spectrophotometer
(Thermo Scientific, Vic, Australia)
Confocal microscopic evaluation of human corneal-limbal
epithelial cells: Apoptosis or necrosis in HCLE cells was
monitored with the Alexa Fluor 488 annexin V/propidium
iodide (PI) assay (Vybrant apoptosis assay kit; Invitrogen,
Australia) using a confocal microscope (FluoView FV1000
confocal laser scanning microscopy; Olympus, Tokyo, Japan).
HCLE cells were seeded at a concentration of 6.5×104 cells/
ml in 75 cm 2 cell culture flasks, and 70%–80% confluent
cells were subjected to 300 mOsm and 500 mOsm media
with and without 10 mM L-carnitine for 16 h. Total cells
(the detached cells were collected after the media were spun
at 239 ×g for 5 min and the remaining adherent cells were
collected with trypsinization) were then stained with Alexa
Fluor 488 Annexin V (5 µl/100 µl), Hoechst 33342 (12.5 µg/
ml), and PI (1 µg/ml) for 15 min at room temperature, and
washed with annexin-binding buffer (Invitrogen, Australia)
before the confocal microscopic evaluation. Images of five
different fields of view for each sample (three samples per
treatment) were captured, and cells were quantified using
ImageJ (National Institutes of Health, Bethesda, MD).
Flow cytometry analysis of human corneal-limbal epithelial
cell responses: Cell apoptosis or necrosis was further evaluated using an Attune Acoustic focusing flow cytometer (Life
Technologies Applied Biosystems, Vic, Australia). Vybrant
cell apoptosis kit (Invitrogen, Australia) containing annexin

© 2013 Molecular Vision

V and PI was used to analyze the physiologic state of the
cells in response to 16 h exposure to isotonic (300 mOsm)
or hypertonic (500 mOsm) conditions with or without
10 mM L-carnitine or D-carnitine. Staining was performed
according to the manufacturer’s instructions. Annexin V
and PI staining was evaluated using the blue/violet laser at
excitation/emission of 480/500 nm (20 mW) and the blue/
red laser at excitation/emission of 490/635 nm, respectively.
Based on the principle that the forward scatter of the laser
light produced by the flow cytometer is proportional to the
volume of the cell, while the side scatter represented cells
with greater structural complexity and granularity and thus
a shrunken cell [53], the cell volume changes in response to
isotonic (300 mOsm) or hyperosmotic (500 mOsm) challenge
with or without 10 mM L-carnitine (16 h) were evaluated
using flow cytometry by gating populations such that the
cells with greater forward scatter constituted the percentage
of cells with intact cell volume while those showing greater
side scatter comprised the shrunken cell population.
Data analysis: All results are presented as mean±standard
deviation (SD). Group means were compared using one-way
analysis of variance (ANOVA) with Bonferroni correction.
The Student t test was performed to compare data comprising
two groups at the p<0.05 level of significance.
RESULTS
Caspase activity in response to hyperosmotic stress in the
presence of L-carnitine: When exposed to the hyperosmotic
medium (500 mOsm) for 16 h, the activity of caspase-8, -9,
and -3/7 were increased significantly (each with p<0.001)
with approximately four-, ten-, and twelve-fold of the value
of isotonic cells, respectively (Figure 1). Adding L-carnitine
(10 mM) during hyperosmotic stress suppressed elevation
of caspase-9 activity significantly (Figure 1A; p=0.0125).
However, no significant effect was observed for L-carnitine
on caspase-8 (Figure 1B) and caspase-3/7 (Figure 1C).
Tumor necrosis factor-α production in response to hyperosmotic stress in the presence of L-carnitine: Exposure of
HCLE cells to 500 mOsm media resulted in a significant
increase in TNF-α production (six-fold, p<0.001). This
increase was counteracted significantly but not fully by the
addition of L-carnitine during the hyperosmotic exposure
(p=0.005; Figure 2).
Induction of cell apoptosis by hyperosmotic stress in the presence of L-carnitine: When the HCLE cells were exposed to
isotonic (300 mOsm) media, confocal microscopic evaluation
revealed a dominant population of healthy cells (Figure 3A),
blue cells stained positive with Hoechst 33342 but not with
annexin V or PI. Hyperosmotic stress (500 mOsm) resulted in
1947
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Figure 1. Activity of caspase-9 (A), caspase-8 (B), and caspase-3/7 (C) during isotonic (300 mOsm) or hyperosmotic (500 mOsm) stress in the
presence or absence of L-carnitine (10 mM). Data are shown as the percentage mean±SD (n=6) over the isotonic medium group (300 mOsm).
* shows the significant difference between cells treated with and without L-carnitine during exposure to 500 mOsm medium osmolarity. #
shows the significant difference from 300 mOsm medium.

an increase in the proportion of damaged/dead cells composed
of early apoptotic (green: positive annexin V staining); late
apoptotic [yellow: positive annexin V (green) + positive PI
staining (red)]; and necrotic (red: positive PI staining) cells
(Figure 3B). Adding L-carnitine to the hyperosmolar medium
resulted in a significant decrease in the number of damaged/
dead cells (i.e., those stained with annexin V and/or PI;
p<0.05; Figure 3C,D).

cells increased significantly (p=0.0001). With addition of
10 mM L-carnitine, however, a significant reduction in the
percentage of apoptotic and necrotic cells was observed
compared to that without treatment with L-carnitine (Figure
3E). These results were similar to that observed when the
cells were cultured under low Ca2+concentration (0.4 mM;
Figure 3D), suggesting that L-carnitine is also effective for
more differentiated cells.

After the cells were transferred to higher calciumcontaining media, confocal microscopic evaluation revealed
a heterogeneous mixed population of differentiated and
undifferentiated cells (data not shown). After the cells were
exposed to hyperosmotic medium (500 mOsm) in the presence of 1.0 mM Ca2+, the percentage of apoptotic and necrotic

Further analysis using f low cytometry (Figure 4)
indicated the percentage of apoptotic and necrotic cells
(Figure 4A, quadrants b, c, d) was comparatively high under
hyperosmotic stress (500 mOsm) compared to the isotonic
control (300 mOsm), and was visibly reduced after 10 mM

Figure 2. Production of tumor
necrosis factor-α by human corneallimbal epithelial cells in response
to isotonic (300 mOsm) or hyperosmotic stress (500 mOsm) with or
without carnitine (10 mM) for 16 h.
Data represent the mean±SD of five
samples. * shows the significant
difference between cells treated
with and without L-car nitine
during exposure to 500 mOsm
medium osmolarity. # shows the
significant difference from 300
mOsm medium.
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Figure 3. Confocal microscopic evaluation of hyperosmotic stress in the presence of 10 mM L-carnitine on the physiological state of HCLE
cells. Representative images of HCLE cells stained with Hoechst (blue), annexin V (green) and PI (red) after 16 h exposure to 300 mOsm
(A), 50 mOsm (B) or 500 mOsm+10 mM L-carnitine (C) media are shown. These images were acquired under the normal culture condition
for HCLE with Ca2+ concentration of 0.4 mM.The percentage of healthy and damaged/dead HCLE cells under the Ca2+ concentration of 0.4
mM (D) or 1.0 mM (E) is shown. * and # represents a statistically significant difference between 500 mOsm and 500 mOsm+L-carnitine or
isotonic (300 mOsm) conditions with Ca2+ concentration of 0.4 and 1.0 mM, respectively.

L-carnitine was added, but not D-carnitine, to the hyperosmolar media (500 mOsm; Figure 4A).
Further statistical analysis showed that the percentage of
damaged (apoptotic and necrotic) cells when the cells were
exposed to hyperosmolar medium increased significantly

from 7% in 300 mOsm to 33% in 500 mOsm (p=0.0014;
Figure 4B). In the presence of L-carnitine, the percentage
of hyperosmolar medium (500 mOsm)–induced apoptotic
and necrotic cells was reduced significantly to approach
that under isotonic conditions (from 33% to 13%, p=0.0294;
1949
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Figure 4. Flow cytometry analysis of the physiologic state of cells in response to isotonic (300 mOsm) media or hyperosmotic stress (500
mOsm) in the presence or absence of L-carnitine or D-carnitine (10 mM). A: Representative flow cytometry dot plots are shown. Quadrant
‘a’=the population of viable healthy cells that stained with neither propidium iodide (PI) nor annexin V. Quadrant ‘b’=the population of cells
staining with annexin V but not PI, indicating an early apoptotic population. Quadrant ‘c’=the population of cells stained with annexin V
and PI, indicating a late apoptotic population. Quadrant ‘d’=the population of cells staining positive for PI but not annexin V, indicating the
complete loss of the cell membrane and thus representing necrotic cells. B: Statistical analysis of percentage of healthy and damaged/dead
HCLE cells is shown. Data represent the mean±SD of eight samples. * represents the statistically significant difference between 500 mOsm
and 500 mOsm + L-carnitine or isotonic (300 mOsm).

Figure 4B). There was no statistically significant difference in
the percentage of damaged cells in response to the exposure

to hyperosmotic medium with or without the presence of
D-carnitine (p>0.05; Figure 4B).
1950
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Figure 5. Flow cytometry evaluation of human corneal-limbal epithelial (HCLE) cell volume changes in response to isotonic (300 mOsm)
medium or hyperosmotic medium (500 mOsm) with or without the presence of L-carnitine or D-carnitine (10 mM). A: Representative dot
plots, (a) population of healthy cells and (b) population of shrunken cells, are shown. B: Percentage number of healthy and shrunken HCLE
cells is shown. Data represent the mean±SD of eight samples. * shows the significant difference in the percentage number of shrunken cells
between 500 mOsm and 500 mOsm + L-carnitine or isotonic (300 mOsm).

L-carnitine modulation of cell volume: Flow cytometry analysis was used to determine cell volume changes in response
to hyperosmolarity with or without L-carnitine. Figure 5A
shows the population of cells with compromised cell volume
(i.e., shrunken cells) in the presence of 500 mOsm media
compared to those under isotonic conditions (300 mOsm).
The percentage of shrunken cells increased from 5% to 31%
(p=0.0012; Figure 5B) in the presence of the hyperosmolar
media. When the cells were supplemented with L-carnitine
during hyperosmotic stress, the percentage of hyperosmotic
stress–induced shrunken cells decreased significantly
from 31% to 11% (p=0.0169; Figure 5B). The percentage
of shrunken cells after treatment with 500 mOsm + 10mM
L-carnitine was not significantly different from that for the
control 300 mOSm treatment (p>0.05; Figure 5B). Adding
D-carnitine to hyperosmotic medium had little effect on the

percentage of shrunken cells compared to that in the absence
of D-carnitine (Figure 5).
DISCUSSION
Tear hyperosmolarity is a central factor in dry eye–related
ocular surface damage, inflammation, and symptoms [11].
The key new finding of this study is that cultured human
corneal epithelial cells can adapt to hyperosmotic stress by
partially restoring the cell volume through uptake of a compatible osmolyte, L-carnitine, and to counteract the deleterious
effects of hyperosmolarity (500 mOsm). L-carnitine regulated
the volume of HCLE cells under hyperosmotic conditions,
eliciting a concomitant reduction in the caspase cascade that
is an inducer of apoptosis. Incubating HCLE in hyperosmolar
media resulted in an increased number of shrunken, apoptotic
and necrotic HCLE cells, accompanied by increased production of TNF-α and elevated activity levels of caspases-3/7, -8.
1951
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and -9. Osmotic shrinkage acting as a signal to apoptosis has
been observed in various cell types including human corneal
epithelial cells [33-35,54,55]. A link between hyperosmotic
stress and the induction of apoptosis in cultured human
ocular surface epithelial cells has been established by several
researchers [33-35]. Proposed pathways include the release of
cytochrome c from mitochondria that then triggers activation
of c-Jun N-terminal kinase, extracellular signal-regulated
kinase mitogen-activated protein kinase, and caspase 3 [33]
and activation of polo-like kinase 3 (Plk3) [18]. Alternative
proposals include a caspase-independent pathway through the
translocation of apoptosis-inducing factor from the mitochondria to the nucleus where apoptosis-inducing factor binds to
DNA and leads to chromatin condensation and cell death [34].
The caspase family plays an important role in apoptosis.
Two major pathways have been identified for induction of
apoptosis [56,57]. One involves participation of the TNF
family of receptors characterized by so-called death domains
on their cytoplasmic tails. The ligation of death receptors by
their ligands activates caspase-8. The other pathway involves
the participation of mitochondria, which releases cytochrome
c to activate caspase-9. Caspases-8 and -9 subsequently activate the downstream effector caspases, such as caspase-3/7,
which are responsible for the proteolytic cleavage of a broad
spectrum of cellular targets ultimately leading to cell death.
In the present work, the activity of caspase-8, -9, and -3/7 of
the HCLE cells subjected to 500 mOsm for 16 h increased
significantly, compared to the value of isotonic cells. These
data suggest that the mitochondria and death receptor pathways might be involved in the hyperosmolarity-induced
apoptosis of HCLE cells.
TNF-α is a potent cytokine produced by many cell types
including human corneal epithelial cells [58,59]. TNF-α is
induced via activation of nuclear factor of activated T-cell-5
(NFAT-5), an important tonicity response gene regulator
and survival factor in hyperosmolar stressed human limbal
epithelial cells [27]. TNF-α elicits a broad spectrum of cellular
responses, including cell proliferation, differentiation, and
apoptosis [60,61]. TNF-α triggers apoptosis by binding to
the TNF-α receptor and subsequently activates caspase-8
[62], which forms a death-signaling complex with tumor
necrosis factor receptor type 1-associated death domain
protein (TRADD), and Fas-associated protein with death
domain (FADD) that can further induce effector caspases
such as caspase-3/7 causing initiation of apoptosis [63,64]. In
agreement with others [55,58], we also observed the induction
of TNF-α expression by hyperosmotic stress, and we found
the increased TNF-α expression was associated with the
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increased population of apoptotic/necrotic cells subjected to
prolonged exposure to hypersomotic stress.
Many types of cells respond to extracellular hyperosmolarity by the accumulation of organic osmolytes, such as
taurine and betaine, which protect cells from the perturbing
effects of high extracellular concentrations of electrolytes
[65-68]. A role for L-carnitine as a stress protectant has been
described in which L-carnitine protects against stress activation of MAP kinases in cultured corneal epithelial cells
[17]. Previous studies have shown that HCLE cells have the
specific transporters OCTN1 and OCTN2 for L-carnitine [49]
and the uptake of L-carnitine is Na+-dependent [69], which
suggests that the uptake of L-carnitine by HCLE cells might
be facilitated in a hyperosmolar environment similar to that
of other osmoprotectants such as betaine and taurine whose
uptake can be facilitated and increased under hyperosmolar
conditions [66,69]. Although L-carnitine uptake by corneal
epithelial cells appeared to be maximal at 0.5 mM under
iso-osmolar conditions [69], 10 mM L-carnitine was used in
the present study to ensure an excess of L-carnitine in the
hyperosmolar culture medium (500 mM). Other researchers
have also shown that L-carnitine at 10 mM is effective as an
osmoprotectant for human primary corneal epithelial cells
[17]. In the present study, we demonstrated that HCLE cells
in the presence of L-carnitine reduced the hyperosmolarityinduced cell shrinkage and subsequent cell apoptosis, therefore enabling increased survival under conditions of high
(external) osmolarity.
L-carnitine is a zwitterionic molecule. Unlike many
other zwitterionic amino acids that are active participants in
cellular metabolism and thus the intracellular concentrations
required for their effective osmoprotection are impossible
to achieve, L-carnitine is not typically metabolized [39]
and has been demonstrated to act as an osmoprotectant in
various mammalian systems and bacteria [39,70-72]. We
characterized the properties of L-carnitine as an osmoprotectant particularly in restoring cell volume and protection
against hyperosmolarity-induced cell apoptosis. L-carnitine’s
ability to regulate hyperosmolarity-induced cell volume
changes might be one of the underlying mechanisms by
which L-carnitine suppresses the initiation of hyperosmotic
stress-induced apoptosis, and contributes to the survival of
cells, although not fully, under hyperosmolar conditions.
D-carnitine (known to be biologically inactive [73]), however,
did not exhibit similar osmoprotection activity. D-carnitine’s
inability to stabilize cell volume under hyperosmotic stress
corresponded with the observation of a lack of protection
for cells under hyperosmotic stress, further supporting the
mechanism of action for L-carnitine as an osmoprotectant:
1952
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regulate cell volume under hyperosmotic stress and ameliorate hyperosmotic stress–induced cell apoptosis.
L-carnitine is antiapoptotic [74,75] and antioxidative
[76], protects Jurkat cells against Fas-mediated apoptosis,
and is a potent inhibitor of caspase-3 [77]. L-carnitine
inhibits the oxidative stress-induced activation of caspase-3
in a dose-dependent manner [76]. Carnitine also reduces
the quantity of oxidant-induced cytosol cytochrome c and
increases antiapoptotic Bcl-xL expression, resulting in
protection of cardiomyocytes from doxorubicin-induced
apoptosis [74]. We found that adding L-carnitine significantly
reduced the activity of caspase-9 presumably not directly but
as the result of preventing activation in HCLE cells during
hyperosmotic stress. Further, L-carnitine also inhibits
Fas-induced apoptosis [78], which can lead to inhibition of
caspase-8 [77]. Interestingly, we found L-carnitine inhibited
hyperosmolarity-induced TNF-α expression but showed little
effect on the activity of caspase-8 under the study conditions.
Caspase-8 is best characterized as the principal upstream
caspase of death receptor signaling, and evidence indicates
caspase-8 is implicated in non-receptor-mediated apoptosis
[79]. In some cell types, lack of caspase-8 does not protect
completely from TNF-induced cell death. TNF-α signaling
uses caspase effectors in addition to caspase-8 [79].
Therefore, we speculate that the extrinsic caspase-8
dependent pathway might play a minor role for HCLE cells at
times of hyperosmotic stress, at least in vitro under our study
conditions where 10 mM L-carnitine was tested. Whether
this concentration is optimal for studying the interactions of
L-carnitine with caspase pathways has yet to be determined,
and further investigation is needed to determine the precise
mechanism of cell death that results from hyperosmolar
stress on corneal epithelial cells and the role of L-carnitine
protection from cell death. In conclusion, the present study
confirmed that L-carnitine can regulate human corneal
epithelial cell volume under hyperosmotic stress and ameliorate the initiation of hyperosmotic stress-induced apoptosis.
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